Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smart Soup in Alzheimer's Disease and MCI
NCT05538507Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of smart soup in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) (6 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Changes of cognitive screening at 1 year, Changes of comprehensive cognitive assessment at 1 year and 9 more. Status: unknown.
02
Drugs
smart soup
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05538507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538507.